[go: up one dir, main page]

AU2415299A - Substituted benzenesulfonamide derivatives and their pharmaceutical use - Google Patents

Substituted benzenesulfonamide derivatives and their pharmaceutical use

Info

Publication number
AU2415299A
AU2415299A AU24152/99A AU2415299A AU2415299A AU 2415299 A AU2415299 A AU 2415299A AU 24152/99 A AU24152/99 A AU 24152/99A AU 2415299 A AU2415299 A AU 2415299A AU 2415299 A AU2415299 A AU 2415299A
Authority
AU
Australia
Prior art keywords
pharmaceutical use
benzenesulfonamide derivatives
substituted benzenesulfonamide
substituted
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU24152/99A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2415299A publication Critical patent/AU2415299A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU24152/99A 1997-12-22 1998-12-18 Substituted benzenesulfonamide derivatives and their pharmaceutical use Abandoned AU2415299A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19757248 1997-12-22
DE19757248 1997-12-22
PCT/EP1998/008333 WO1999032466A1 (en) 1997-12-22 1998-12-18 Substituted benzenesulfonamide derivatives and their pharmaceutical use

Publications (1)

Publication Number Publication Date
AU2415299A true AU2415299A (en) 1999-07-12

Family

ID=7853006

Family Applications (1)

Application Number Title Priority Date Filing Date
AU24152/99A Abandoned AU2415299A (en) 1997-12-22 1998-12-18 Substituted benzenesulfonamide derivatives and their pharmaceutical use

Country Status (6)

Country Link
AR (1) AR014406A1 (en)
AU (1) AU2415299A (en)
CO (1) CO5011105A1 (en)
PE (1) PE20000127A1 (en)
WO (1) WO1999032466A1 (en)
ZA (1) ZA9811705B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6191160B1 (en) 1998-11-10 2001-02-20 Merck & Co., Inc. Spiro-indolines as Y5 receptor antagonists
FR2792314B1 (en) * 1999-04-15 2001-06-01 Adir NOVEL AMINOTRIAZOLE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
US6218408B1 (en) 1999-06-30 2001-04-17 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (bicyclics)
US6989379B1 (en) 1999-04-22 2006-01-24 H. Lundbick A/S Selective NPY (Y5) antagonists
US6340683B1 (en) 1999-04-22 2002-01-22 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (triazines)
DE60034783T2 (en) * 1999-04-22 2008-01-31 H. Lundbeck A/S, Valby SELECTIVE NPY (Y5) ANTAGONISTS
US6214853B1 (en) 1999-06-30 2001-04-10 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (bicyclics)
US7273880B2 (en) 1999-06-30 2007-09-25 H. Lunbeck A/S Selective NPY (Y5) antagonists
US6222040B1 (en) 1999-06-30 2001-04-24 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (tricyclics)
US6225330B1 (en) 1999-06-30 2001-05-01 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (tricyclics)
CA2389681C (en) 1999-11-26 2010-11-02 Shionogi & Co., Ltd. Npy y5 antagonist
WO2001064674A1 (en) 2000-03-01 2001-09-07 Janssen Pharmaceutica N.V. 2,4-disubstituted thiazolyl derivatives
FR2815346B1 (en) * 2000-10-13 2004-02-20 Servier Lab NOVEL AMINOTRIAZOLONE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
JP2005508841A (en) * 2001-03-29 2005-04-07 スミスクライン・ビーチャム・コーポレイション Compounds and methods
CA2403307A1 (en) 2001-10-23 2003-04-23 Neurogen Corporation Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives
TW200303742A (en) * 2001-11-21 2003-09-16 Novartis Ag Organic compounds
CN1794989A (en) * 2003-04-14 2006-06-28 药物研发有限责任公司 N-(((((1,3-thiazol-2-yl)amino)carbonyl)phenyl)sulfonyl)phenylalanine derivatives and related compounds for the treatment of diabetes
CN1812977A (en) 2003-04-30 2006-08-02 药物研发有限责任公司 Substituted carboxylic acids
CN101084200A (en) * 2004-10-08 2007-12-05 詹森药业有限公司 1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives
GB0526257D0 (en) 2005-12-22 2006-02-01 Novartis Ag Organic compounds
EP3052190A4 (en) * 2013-10-01 2017-07-19 New York University Amino, amido, and heterocyclic compounds as modulators of rage activity and uses thereof
JP2023508909A (en) 2019-12-20 2023-03-06 イケナ オンコロジー， インコーポレイテッド 4-Phenyl-N-(phenyl)thiazol-2-amine Derivatives and Related Compounds as Aryl Hydrocarbon Receptor (AHR) Agonists, For example, for the Treatment of Angiogenesis-Related Disorders or Inflammatory Diseases
WO2025017207A1 (en) * 2023-07-20 2025-01-23 Cemm - Forschungszentrum Für Molekulare Medizin Gmbh Inhibitors of smndc1 and their therapeutic use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3776765A (en) * 1972-02-28 1973-12-04 Cities Service Co Process for protecting a substrate with an n{11 substituted aminoarylsulfonamide intumescent agent
FR2701480B1 (en) * 1993-02-15 1995-05-24 Sanofi Elf Compounds with a sulfamoyl and amidino group, process for their preparation and pharmaceutical compositions containing them.
AU3201095A (en) * 1994-07-27 1996-02-22 G.D. Searle & Co. Substituted thiazoles for the treatment of inflammation

Also Published As

Publication number Publication date
ZA9811705B (en) 1999-09-07
CO5011105A1 (en) 2001-02-28
WO1999032466A1 (en) 1999-07-01
AR014406A1 (en) 2001-02-28
PE20000127A1 (en) 2000-03-14

Similar Documents

Publication Publication Date Title
AU2415299A (en) Substituted benzenesulfonamide derivatives and their pharmaceutical use
AU2505795A (en) 1-arylpyrimidine derivatives and pharmaceutical use thereof
AU6526896A (en) Substituted aromatic compounds and their pharmaceutical use
IL117962A0 (en) Sulfonamide derivatives and pharmaceutical compositions containing the same
IL136941A0 (en) Sulphonamide derivatives and pharmaceutical compositions containing the same
IL136940A0 (en) Sulphonamide derivatives and pharmaceutical compositions containing the same
ZA985618B (en) Sulfonamide compounds and pharmaceutical use thereof
AU1618697A (en) Novel compounds and pharmaceutical use thereof
AU5387898A (en) Pharmaceutical agents
IL116916A0 (en) Substituted biphenyl sulfonamide derivatives and pharmaceutical compositions containg the same
AU4204697A (en) Tetrahydroisoquinoline derivatives and their pharmaceutical use
AU5856898A (en) Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them
AU5161399A (en) N-benzocycloalkyl-amide derivatives and their use as medicaments
AU7449198A (en) Phthalimide derivatives and pharmaceutical containing said derivatives
AU6120298A (en) 2-peperazinone-1-acetic acid derivatives and their use
HUP9802590A3 (en) Indan-, benzothiophene-, benzofuran- and indolesulfonamide derivatives, their use and pharmaceutical compositions containing them
AUPP672198A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AU732214C (en) Biphenyl derivatives and drug composition
AU7681498A (en) Pharmaceutical composition and use thereof
AU4964597A (en) Benzenesulfonamide derivatives and medicaments comprising said derivatives
AU7551896A (en) 1-azabicycloheptane derivatives and their pharmaceutical use
AU3107497A (en) Asialotrisaccharide moranoline derivatives and drugs
AU1698899A (en) N-acetylserotonin derivatives and uses thereof
AU8031698A (en) Indane compounds and their pharmaceutical use
AU6520198A (en) Quinolinomorphinane derivatives and medicinal use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase